NPPB and congenital rubella syndrome: Biomarkers, such as serum creatinine, used as kidney injury markers, BNP/NT-pro BNP, or cardiac Troponin T levels used for myocardial injury, have several limitations for projecting CRS progression in a chronic setting (Goffredo et al., 2021).